Companies in #Muscular Dystrophy
Found 1 company operating in this sector.
Epicrispr Biotechnologies
PrivateEpigenetic therapies for facioscapulohumeral muscular dystrophy (FSHD). Lead program EPI-321 targets the genetic root cause. Also researching alpha-1 antitrypsin deficiency and familial hypercholesterolemia.